v3.25.1
Organization and Nature of Business - Schedule of Investments in Subsidiaries (Details)
3 Months Ended
Mar. 31, 2025
shares
VAXIMM AG (“VAXIMM”) [Member]  
Schedule of Investments in Subsidiaries [Line Items]  
Share capital 1,091,203,754
Percentage of ownership 100.00%
Principal activities Biotech (drug development)
Country of incorporation Switzerland
RMC Co., Ltd. (“RMC”) [Member]  
Schedule of Investments in Subsidiaries [Line Items]  
Share capital 35,000,000
Percentage of ownership 100.00%
Principal activities Medical device distribution
Country of incorporation Republic of Korea
Darnatein Co., Ltd. (“Darnatein”) [Member]  
Schedule of Investments in Subsidiaries [Line Items]  
Share capital 6,466,667,000
Percentage of ownership 100.00%
Principal activities Biotech (drug development)
Country of incorporation Republic of Korea
OSR Holdings, Inc. [Member]  
Schedule of Investments in Subsidiaries [Line Items]  
Share capital 2,826,969
Percentage of ownership 100.00%
Principal activities SPAC
Country of incorporation The United States